简体
简体中文
繁體中文

Biodesix, Inc. BDSX

等待开盘 04-02 09:30:00 美东时间

14.76

+0.260

+1.79%

华盛通华盛通
立即下载
  • 最 高15.20
  • 今 开14.48
  • 成交量 2.66万股
  • 最 低 14.435
  • 昨 收 14.50
  • 总市值 1.46亿
  • 52周最高 20.21
  • 市盈率 --
  • 换手率 0.27%
  • 52周最低 3.436
  • 委 比 -11.50%
  • 总股本 985.84万
  • 历史最高 639.80
  • 量 比 0.45
  • 振 幅 5.28%
  • 历史最低 3.436
  • 每 手 1
  • 风险率 3.07%

个股概要

财务分析

公司资料

相关新闻

分红派息

  • 分时图
  • 日k
  • 周k
  • 月k

相关新闻

更多
  • Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis

    Biodesix的Nodify CDT®测试在一项涉及1,100名患者的回顾性分析中展示了其在肺癌早期检测中的稳定临床表现。该研究发表于《Future Oncology》,表明Nodify CDT®能在4-30毫米肺结节中以高特异性(91-97%)识别肺癌高风险患者。数据跨四个不同临床研究和48家美国临床机构,显示其在真实世界中的高度适用性。专家指出,该测试通过提供可靠的生物标志物检测,有助于临床医生更早确定治疗方案,从而改善患者预后。

    03-20 12:06

  • William Blair Upgrades Biodesix to Outperform

    William Blair analyst Brian Weinstein upgrades Biodesix (NASDAQ:BDSX) from Market Perform to Outperform.

    02-28 05:43

  • Biodesix Earnings Report: Q4 Overview

    The Q4 earnings report for Biodesix (NASDAQ:BDSX) was released on Thursday, Feb...

    02-27 05:04

  • Biodesix Sees FY2026 Sales $106.000M-$112.000M vs $105.624M Est

    2026 Financial OutlookThe Company anticipates generating between $106-112 million in total revenue in 2026, the mid-point representing 23% growth over 2025 total revenue, and expects continued improvement toward

    02-27 05:04

  • Earnings Scheduled For February 26, 2026

    Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...

    02-26 19:11

  • Biodesix management to join TD Cowen and Barclays investor conference fireside chats

    Biodesix management to join TD Cowen and Barclays investor conference fireside chats Biodesix Inc. said its management team will participate in TD Cowen’s 46th Annual Health Care Conference with a fireside chat on March 3, 2026 at 2:30 PM ET in Boston, and in the Barclays 28th Annual Global Healthca

    02-24 19:00

  • Biodesix to Participate in Upcoming Investor Conferences

    Biodesix, Inc. announced that its management team will participate in two upcoming investor conferences. The first is TD Cowen's 46th Annual Health Care Conference on March 3, 2026, in Boston, and the second is Barclays' 28th Annual Global Healthcare Conference on March 11, 2026, in Miami. Both events will feature fireside chats available live and for replay on Biodesix's website.

    02-24 11:00

  • Biodesix Inc. Chief Development Officer Gary Anthony Pestano Reports Disposal of Common Shares

    Biodesix Inc. Chief Development Officer Gary Anthony Pestano Reports Disposal of Common Shares Gary Anthony Pestano, Chief Development Officer of Biodesix Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief wa

    02-12 07:04

  • Biodesix CFO Robin Harper Cowie Reports Disposal of Common Shares

    Biodesix CFO Robin Harper Cowie Reports Disposal of Common Shares Robin Harper Cowie, Chief Financial Officer, Secretary & Treasurer of Biodesix Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created

    02-12 07:03

  • Biodesix CEO Scott Hutton Reports Disposal of Common Shares

    Biodesix CEO Scott Hutton Reports Disposal of Common Shares Scott Hutton, President & CEO of Biodesix Inc., reported the disposal of common shares of Biodesix Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using gene

    02-12 07:03